Molecular markers of the risk of oral cancer.

Oral cancer is the most common neoplasm of the head and neck. Worldwide, the annual incidence of new cases exceeds 300,000. The disease causes great morbidity, and the five-year survival rate of le...

[1]  A. Sabichi,et al.  Cancer chemoprevention: progress and promise. , 1998, Journal of the National Cancer Institute.

[2]  N D Le,et al.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  S. Lippman,et al.  Predicting cancer development in oral leukoplakia: ten years of translational research. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer treatment and research.

[5]  S. Lippman,et al.  Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment , 1996, Nature Medicine.

[6]  S. Lippman,et al.  Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. , 1998, Journal of the National Cancer Institute.

[7]  R H Hruban,et al.  Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.

[8]  J. Sudbø,et al.  DNA content as a prognostic marker in patients with oral leukoplakia. , 2001, The New England journal of medicine.